|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huarte M and Rinn JL: Large non-coding
RNAs: Missing links in cancer? Human Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar
|
|
4
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu FJ, Zheng JJ, Dong PH and Fan XM: Long
non-coding RNAs and hepatocellular carcinoma. Mol Clin Oncol.
3:13–17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Redis RS, Sieuwerts AM, Look MP, Tudoran
O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, et al:
CCAT2, a novel long non-coding RNA in breast cancer: Expression
study and clinical correlations. Oncotarget. 4:1748–1762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gutschner T, Hammerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A,
Lu Z, Wu F and Mo YY: LncRNA loc285194 is a p53-regulated tumor
suppressor. Nucleic Acids Res. 41:4976–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye LC, Zhu X, Qiu JJ, Xu J and Wei Y:
Involvement of long non-coding RNA in colorectal cancer: From
benchtop to bedside (Review). Oncol Lett. 9:1039–1045. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han D, Wang M, Ma N, Xu Y, Jiang Y and Gao
X: Long noncoding RNAs: Novel players in colorectal cancer. Cancer
Lett. 361:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schneider C, King RM and Philipson L:
Genes specifically expressed at growth arrest of mammalian cells.
Cell. 54:787–793. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kino T, Hurt DE, Ichijo T, Nader N and
Chrousos GP: Noncoding RNA gas5 is a growth arrest- and
starvation-associated repressor of the glucocorticoid receptor. Sci
Signal. 3:ra82010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F
and Song Y: A critical role for the long non-coding RNA GAS5 in
proliferation and apoptosis in non-small-cell lung cancer. Mol
Carcinog. 54 Suppl 1:E1–E12. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pickard MR, Mourtada-Maarabouni M and
Williams GT: Long non-coding RNA GAS5 regulates apoptosis in
prostate cancer cell lines. Biochim Biophys Acta. 1832:1613–1623.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mourtada-Maarabouni M, Pickard MR, Hedge
VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA,
controls apoptosis and is downregulated in breast cancer. Oncogene.
28:195–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krell J, Frampton AE, Mirnezami R, Harding
V, De Giorgio A, Alonso Roca L, Cohen P, Ottaviani S, Colombo T,
Jacob J, et al: Growth arrest-specific transcript 5 associated
snoRNA levels are related to p53 expression and DNA damage in
colorectal cancer. PLoS One. 9:e985612014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin D, He X, Zhang E, Kong R, De W and
Zhang Z: Long noncoding RNA GAS5 affects cell proliferation and
predicts a poor prognosis in patients with colorectal cancer. Med
Oncol. 31:2532014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng Y, Song D, Xiao K, Yang C, Ding Y,
Deng W and Tong S: LncRNA GAS5 contributes to lymphatic metastasis
in colorectal cancer. Oncotarget. 7:83727–83734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C,
Xu M, Wu F and Mo YY: Negative regulation of lncRNA GAS5 by miR-21.
Cell Death Differ. 20:1558–1568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo C, Song WQ, Sun P, Jin L and Dai HY:
LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in
endometrial cancer cells. J Biomed Sci. 22:1002015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY,
Gong W and Quan ZW: Long non-coding RNA CCAT1 promotes gallbladder
cancer development via negative modulation of miRNA-218-5p. Cell
Death Dis. 6:e15832015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Li A, Wu J, He Y, Yu H, Chai R and
Li H: MiR-182-5p protects inner ear hair cells from
cisplatin-induced apoptosis by inhibiting FOXO3a. Cell Death Dis.
7:e23622016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang CY, Shirley N, Genc Y, Shi B and
Langridge P: Phosphate utilization efficiency correlates with
expression of low-affinity phosphate transporters and noncoding
RNA, IPS1, in barley. Plant Physiol. 156:1217–1229. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang C, Han C, Zhang Y and Liu F: LncRNA
PVT1 regulate expression of HIF1α via functioning as
ceRNA for miR199a5p in nonsmall cell lung cancer under hypoxia. Mol
Med Rep. 17:1105–1110. 2018.PubMed/NCBI
|
|
28
|
Lan X and Liu X: LncRNA SNHG1 functions as
a ceRNA to antagonize the effect of miR-145a-5p on the
down-regulation of NUAK1 in nasopharyngeal carcinoma cell. J
Cell Mol Med. Mar 25–2018.(Epub ahead of print). doi:
10.1111/jcmm.13497. View Article : Google Scholar
|
|
29
|
Li J, Wang X, Tang J, Jiang R, Zhang W, Ji
J and Sun B: HULC and Linc00152 act as novel biomarkers in
predicting diagnosis of hepatocellular carcinoma. Cell Physiol
Biochem. 37:687–696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li J, Huang H, Li Y, Li L, Hou W and You
Z: Decreased expression of long non-coding RNA GAS5 promotes cell
proliferation, migration and invasion, and indicates a poor
prognosis in ovarian cancer. Oncol Rep. 36:3241–3250. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Li Y, Huang S, He K, Zhao M, Lin H,
Li D, Qian J, Zhou C, Chen Y and Huang C: Long non-coding RNA
growth arrest specific transcript 5 acts as a tumour suppressor in
colorectal cancer by inhibiting interleukin-10 and vascular
endothelial growth factor expression. Oncotarget. 8:13690–13702.
2017.PubMed/NCBI
|
|
32
|
Lin M, Chen W, Huang J, Gao H, Ye Y, Song
Z and Shen X: MicroRNA expression profiles in human colorectal
cancers with liver metastases. Oncol Rep. 25:739–747.
2011.PubMed/NCBI
|
|
33
|
Liu L, Chen L, Xu Y, Li R and Du X:
microRNA-195 promotes apoptosis and suppresses tumorigenicity of
human colorectal cancer cells. Biochem Biophys Res Commun.
400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Segura MF, Hanniford D, Menendez S, Reavie
L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A,
Bogunovic D, et al: Aberrant miR-182 expression promotes melanoma
metastasis by repressing FOXO3 and microphthalmia-associated
transcription factor. Proc Natl Acad Sci USA. 106:1814–1819. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cao LL, Xie JW, Lin Y, Zheng CH, Li P,
Wang JB, Lin JX, Lu J, Chen QY and Huang CM: miR-183 inhibits
invasion of gastric cancer by targeting Ezrin. Int J Clin Exp
Pathol. 7:5582–5594. 2014.PubMed/NCBI
|
|
37
|
Tang T, Wong HK, Gu W, Yu MY, To KF, Wang
CC, Wong YF, Cheung TH, Chung TK and Choy KW: MicroRNA-182 plays an
onco-miRNA role in cervical cancer. Gynecol Oncol. 129:199–208.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cekaite L, Rantala JK, Bruun J, Guriby M,
Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe
RA, et al: MiR-9, −31, and −182 deregulation promote proliferation
and tumor cell survival in colon cancer. Neoplasia. 14:868–879.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hirata H, Ueno K, Shahryari V, Tanaka Y,
Tabatabai ZL, Hinoda Y and Dahiya R: Oncogenic miRNA-182-5p targets
Smad4 and RECK in human bladder cancer. PLoS One. 7:e510562012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chiang CH, Hou MF and Hung WC:
Up-regulation of miR-182 by β-catenin in breast cancer
increases tumorigenicity and invasiveness by targeting the matrix
metalloproteinase inhibitor RECK. Biochim Biophys Acta.
1830:3067–3076. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yao J, Xu C, Fang Z, Li Y, Liu H, Wang Y,
Xu C and Sun Y: Androgen receptor regulated microRNA miR-182-5p
promotes prostate cancer progression by targeting the ARRDC3/ITGB4
pathway. Biochem Biophys Res Commun. 474:213–219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang YQ, Guo RD, Guo RM, Sheng W and Yin
LR: MicroRNA-182 promotes cell growth, invasion, and
chemoresistance by targeting programmed cell death 4 (PDCD4) in
human ovarian carcinomas. J Cell Biochem. 114:1464–1473. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang X, Chen L, Jin H, Wang S, Zhang Y,
Tang X and Tang G: Screening miRNAs for early diagnosis of
colorectal cancer by small RNA deep sequencing and evaluation in a
Chinese patient population. Onco Targets Ther. 9:1159–1166.
2016.PubMed/NCBI
|
|
44
|
Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang
Z, Wang X, Lin Y and Mao Y: Downregulation of microRNA-182-5p
contributes to renal cell carcinoma proliferation via activating
the AKT/FOXO3a signaling pathway. Mol Cancer. 13:1092014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Leung WK, He M, Chan AW, Law PT and Wong
N: Wnt/β-catenin activates MiR-183/96/182 expression in
hepatocellular carcinoma that promotes cell invasion. Cancer Lett.
362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang J, Li J, Shen J, Wang C, Yang L and
Zhang X: MicroRNA-182 downregulates metastasis suppressor 1 and
contributes to metastasis of hepatocellular carcinoma. BMC Cancer.
12:2272012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Guo S and Sonenshein GE: Forkhead box
transcription factor FOXO3a regulates estrogen receptor alpha
expression and is repressed by the Her-2/neu/phosphatidylinositol
3-kinase/Akt signaling pathway. Mol Cell Biol. 24:8681–8690. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lu M, Xiang J, Xu F, Wang Y, Yin Y and
Chen D: The expression and significance of pThr32-FOXO3a in human
ovarian cancer. Med Oncol. 29:1258–1264. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yu C, Zhang Z, Liao W, Zhao X, Liu L, Wu
Y, Liu Z, Li Y, Zhong Y, Chen K, et al: The tumor-suppressor gene
Nkx2.8 suppresses bladder cancer proliferation through upregulation
of FOXO3a and inhibition of the MEK/ERK signaling pathway.
Carcinogenesis. 33:678–686. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dubrovska A, Kim S, Salamone RJ, Walker
JR, Maira SM, García-Echeverría C, Schultz PG and Reddy VA: The
role of PTEN/Akt/PI3K signaling in the maintenance and viability of
prostate cancer stem-like cell populations. Proc Natl Acad Sci USA.
106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang L, Xie S, Jamaluddin MS, Altuwaijri
S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH, et al: Induction
of androgen receptor expression by phosphatidylinositol
3-kinase/Akt downstream substrate, FOXO3a, and their roles in
apoptosis of LNCaP prostate cancer cells. J Biol Chem.
280:33558–33565. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Habashy HO, Rakha EA, Aleskandarany M,
Ahmed MA, Green AR, Ellis IO and Powe DG: FOXO3a nuclear
localisation is associated with good prognosis in luminal-like
breast cancer. Breast Cancer Res Treat. 129:11–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X
and Tang H: MicroRNA-182 targets cAMP-responsive element-binding
protein 1 and suppresses cell growth in human gastric
adenocarcinoma. FEBS J. 279:1252–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sun Y, Fang R, Li C, Li L, Li F, Ye X and
Chen H: Hsa-mir-182 suppresses lung tumorigenesis through down
regulation of RGS17 expression in vitro. Biochem Biophys Res
Commun. 396:501–507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yan D, Dong XD, Chen X, Yao S, Wang L,
Wang J, Wang C, Hu DN, Qu J and Tu L: Role of microRNA-182 in
posterior uveal melanoma: Regulation of tumor development through
MITF, BCL2 and cyclin D2. PLoS One. 7:e409672012. View Article : Google Scholar : PubMed/NCBI
|
